Former Meridian COO Kang Named President of Amedisys Hospice

Kacy Kang, former chief operations officer for Meridian Senior Living, has been tapped as the new president of hospice at Amedisys (NASDAQ: AMED). While Amedisys has not yet announced Kang’s new role, updates to his LinkedIn page reflect his new title.  Kang left Meridian amid a shake up of the company’s leadership team in which […]

Kusserow: Amedisys Turned COVID-19 ‘Headwinds to Tailwinds’

Like many health care providers, Baton Rouge, La.-based Amedisys Inc. (NASDAQ: AMED) did not come out of 2020 unscathed by the coronavirus pandemic. Nevertheless, the company’s hospice segment grew during the outbreak and is anticipated to continue expanding, largely through acquisitions. Amedisys is benefitting from demographic tailwinds of the aging population and rising utilization that […]

Amedisys Back in the M&A Market After COVID Recovery

Amedisys, Inc. (NASDAQ: AMED) anticipates more hospice merger and acquisitions in 2020 despite raging COVID-19 headwinds. Recovering from a drop in referrals and rising COVID-related costs during the first and second quarters, the company expects their hospice segment to grow consistently in coming years. The company has been very active in the M&A market. Acquisitions […]

Amedisys Closes $235 Million AseraCare Deal

Amedisys, Inc. (NASDAQ:AMED) has completed its acquisition of Homecare Preferred Choice, Inc., doing business as AseraCare Hospice. Amedisys acquired 100% ownership of AseraCare for a cash price of $235 million.  AseraCare operates 44 hospice locations throughout 14 states with an average daily census that exceeds 2,100. The company generates $117 million in revenue annually. With […]

Amedisys Poised for COVID-19 Recovery, Further Hospice Growth

The Amedisys, Inc. (NASDAQ: AMED) hospice segment saw a drop in referrals and rising costs stemming from the COVID-19 pandemic during the first quarter of this year. Though the outbreak creates industry-wide uncertainty about the future, demographic tailwinds, de novo activity and acquisitions show promise for a strong recovery, including the company’s $235 million purchase […]

Amedisys to Acquire AseraCare Hospice for $235 Million

Hospice and home health provider Amedisys, Inc. (NASDAQ:AMED) has entered into a definitive agreement to purchase Texas-based AseraCare Hospice for a cash purchase price of $235 million. Amedisys has had its eye on AseraCare for a number of years. “In 2016 we actually approached the AseraCare, and at that time they weren’t for sale. We’ve […]

Investors Lean Towards Hospice Amid Disruption in Home Health Space

Investors and companies seeking strategic acquisitions are showing rising interest in an already booming hospice M&A market as they await the fallout from home health care’s transition to the Patient Driven Groupings Model (PDGM), according to an analysis by Provident Healthcare Partners, an investment bank focused on the middle market in the health care space. […]

Amedisys Closes Asana Hospice Acquisition

Amedisys, Inc. (NASDAQ: AMED) has closed its purchase of Asana Hospice for an undisclosed amount. Asana Hospice, which operates eight locations in Pennsylvania, Ohio, Missouri, Kansas and Texas, has an average daily census of 540. Following closure of this transaction, Amedisys hospice portfolio will rise to 146 locations in 33 states. “Since our founding, Asana […]

Amedisys to Purchase Asana Hospice

Amedisys, Inc. (NASDAQ: AMED) has entered into a definitive agreement to purchase Asana Hospice for an undisclosed amount. The transaction is expected to close Jan. 1, 2020. Amedisys has been doubling down on hospice acquisitions this year, building up its hospice footprint as the company braces for disruption to its home health care business stemming […]